Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-16-00260R2_FINAL_Nichols_25012017.pdf
[2] https://www.ncbi.nlm.nih.gov/pubmed/?term=Impact%20of%20azithromycin%20on%20the%20clinical%20and%20antimicrobial%20effectiveness%20of%20tobramycin%20in%20the%20treatment%20of%20cystic%20fibrosis
[3] https://www.ecfs.eu/research-article-keywords/azithromycin
[4] https://www.ecfs.eu/research-article-keywords/clinical-trial
[5] https://www.ecfs.eu/research-article-keywords/drug-interaction
[6] https://www.ecfs.eu/research-article-keywords/inhaled-antibiotics
[7] https://www.ecfs.eu/research-article-keywords/mexxy
[8] https://www.ecfs.eu/research-article-keywords/pseudomonas-aeruginosa
[9] https://www.ecfs.eu/research-article-keywords/tobramycin
[10] https://www.ecfs.eu/resource-guideline-type/other-guidelines